China's Fosun to buy remaining stake in Henlius Biotech, valuing drugmaker at $1.7b

China's Fosun to buy remaining stake in Henlius Biotech, valuing drugmaker at $1.7b

Photo: Bloomberg

25 June, 2024

Fosun Henlius Biotech

Printed by Unregistered user on Sat, 16 Aug 2025 18:51:17 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Fosun Health Capital leads DSciLab’s angel round and 19 Greater China deals worth over $687m

BNP Paribas to acquire Fosun's around 9% stake in Belgian insurer Ageas

Read more from Greater China

Chinese tech firms ride new wave of AI-powered wearables market

Bridgewater sold all its US-listed China stocks, worth $1.5b, in Q2 2025